Results 51 - 60 of 258 : Previous 2 3 4 5 6 7 8 9 10 Next
Put some money to work in this wacky market.
Vertex on the Verge of Victory
Financials, schminancials -- clinical trial results are where it's at.
Recession Schmession, This Industry Is On Fire
Pharma is cutting costs and this industry is only too happy to help.
The drugmaker posts strong earnings, but the good times may not last.
Drug Duo SEAS Disappointment -- Again
Merck and Schering continue their string of bad luck.
Foolish Forecast: How Quickly Can Merck Turn It Around?
Views you can use to get clues on the news.
Will a New Use Help Schering-Plough's Near-Blockbuster Drug?
Delaying relapses probably won't be enough to get its Pegintron approved as a treatment for melanoma.
Foolish Forecast: J&J Trudges Along
Views you can use to get clues on tomorrow's news.
A Drug to Fertilize Schering-Plough's Growth?
A fertility treatment displays promising results in a phase 3 trial.
Buffett avoids five types of stocks. You should, too.
Legal Information © 1995 - 2008 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK